Expression of PRMT5 in lung adenocarcinoma and its significance in epithelial-mesenchymal transition
- 1 July 2014
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 45 (7) , 1397-1405
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Arginine methylation controls growth regulation by E2F‐1The EMBO Journal, 2012
- Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladderNature Genetics, 2011
- MAP3K4/CBP-Regulated H2B Acetylation Controls Epithelial-Mesenchymal Transition in Trophoblast Stem CellsCell Stem Cell, 2011
- Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinomaNature, 2011
- Prmt5 is essential for early mouse development and acts in the cytoplasm to maintain ES cell pluripotencyGenes & Development, 2010
- The expression of myogenic microRNAs indirectly requires protein arginine methyltransferase (Prmt)5 but directly requires Prmt4Nucleic Acids Research, 2010
- Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell CarcinomaScience, 2010
- Methylation of Ribosomal Protein S10 by Protein-arginine Methyltransferase 5 Regulates Ribosome BiogenesisJournal of Biological Chemistry, 2010
- PRMT5 is required for cell-cycle progression and p53 tumor suppressor functionNucleic Acids Research, 2009
- Low levels of miR‐92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphomaThe EMBO Journal, 2007